Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 28, 2022

SELL
$54.1 - $110.08 $269,959 - $549,299
-4,990 Closed
0 $0
Q4 2021

Jan 25, 2022

BUY
$94.25 - $115.99 $22,997 - $28,301
244 Added 5.14%
4,990 $534,000
Q3 2021

Oct 27, 2021

BUY
$80.98 - $109.47 $19,597 - $26,491
242 Added 5.37%
4,746 $488,000
Q2 2021

Aug 10, 2021

BUY
$82.78 - $101.0 $45,115 - $55,045
545 Added 13.77%
4,504 $396,000
Q1 2021

Apr 28, 2021

BUY
$90.71 - $108.28 $359,120 - $428,680
3,959 New
3,959 $385,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.38B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Spearhead Capital Advisors, LLC Portfolio

Follow Spearhead Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.